1. Home
  2. TUYA vs EVO Comparison

TUYA vs EVO Comparison

Compare TUYA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUYA
  • EVO
  • Stock Information
  • Founded
  • TUYA 2014
  • EVO 1993
  • Country
  • TUYA China
  • EVO Germany
  • Employees
  • TUYA N/A
  • EVO N/A
  • Industry
  • TUYA Computer Software: Prepackaged Software
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUYA Technology
  • EVO Health Care
  • Exchange
  • TUYA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • TUYA 1.6B
  • EVO 1.4B
  • IPO Year
  • TUYA 2021
  • EVO 2021
  • Fundamental
  • Price
  • TUYA $2.33
  • EVO $3.88
  • Analyst Decision
  • TUYA Strong Buy
  • EVO Strong Buy
  • Analyst Count
  • TUYA 1
  • EVO 1
  • Target Price
  • TUYA $3.49
  • EVO $7.00
  • AVG Volume (30 Days)
  • TUYA 1.5M
  • EVO 45.0K
  • Earning Date
  • TUYA 11-17-2025
  • EVO 11-05-2025
  • Dividend Yield
  • TUYA 4.66%
  • EVO N/A
  • EPS Growth
  • TUYA N/A
  • EVO N/A
  • EPS
  • TUYA 0.05
  • EVO N/A
  • Revenue
  • TUYA $318,493,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • TUYA $10.16
  • EVO N/A
  • Revenue Next Year
  • TUYA $12.68
  • EVO $10.78
  • P/E Ratio
  • TUYA $49.07
  • EVO N/A
  • Revenue Growth
  • TUYA 22.29
  • EVO N/A
  • 52 Week Low
  • TUYA $1.46
  • EVO $2.84
  • 52 Week High
  • TUYA $4.63
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • TUYA 40.51
  • EVO 52.60
  • Support Level
  • TUYA $2.24
  • EVO $3.85
  • Resistance Level
  • TUYA $2.47
  • EVO $4.04
  • Average True Range (ATR)
  • TUYA 0.11
  • EVO 0.08
  • MACD
  • TUYA -0.02
  • EVO -0.00
  • Stochastic Oscillator
  • TUYA 20.00
  • EVO 28.00

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: